ID UBP5_YEAST Reviewed; 805 AA. AC P39944; D3DM51; DT 01-FEB-1995, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1995, sequence version 1. DT 27-MAR-2024, entry version 180. DE RecName: Full=Ubiquitin carboxyl-terminal hydrolase 5; DE EC=3.4.19.12; DE AltName: Full=Deubiquitinating enzyme 5; DE AltName: Full=Ubiquitin thioesterase 5; DE AltName: Full=Ubiquitin-specific-processing protease 5; GN Name=UBP5; OrderedLocusNames=YER144C; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=7871889; DOI=10.1002/yea.320101114; RA Xiao W., Fontanie T., Tang M.; RT "UBP5 encodes a putative yeast ubiquitin-specific protease that is related RT to the human Tre-2 oncogene product."; RL Yeast 10:1497-1502(1994). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169868; RA Dietrich F.S., Mulligan J.T., Hennessy K.M., Yelton M.A., Allen E., RA Araujo R., Aviles E., Berno A., Brennan T., Carpenter J., Chen E., RA Cherry J.M., Chung E., Duncan M., Guzman E., Hartzell G., Hunicke-Smith S., RA Hyman R.W., Kayser A., Komp C., Lashkari D., Lew H., Lin D., Mosedale D., RA Nakahara K., Namath A., Norgren R., Oefner P., Oh C., Petel F.X., RA Roberts D., Sehl P., Schramm S., Shogren T., Smith V., Taylor P., Wei Y., RA Botstein D., Davis R.W.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome V."; RL Nature 387:78-81(1997). RN [3] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [4] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). CC -!- CATALYTIC ACTIVITY: CC Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide CC and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76- CC residue protein attached to proteins as an intracellular targeting CC signal).; EC=3.4.19.12; CC -!- MISCELLANEOUS: Present with 300 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U10082; AAC48928.1; -; Genomic_DNA. DR EMBL; U18917; AAB64671.1; -; Genomic_DNA. DR EMBL; BK006939; DAA07805.1; -; Genomic_DNA. DR PIR; S50277; S50277. DR RefSeq; NP_011071.3; NM_001179034.3. DR AlphaFoldDB; P39944; -. DR SMR; P39944; -. DR BioGRID; 36893; 87. DR DIP; DIP-1716N; -. DR IntAct; P39944; 7. DR MINT; P39944; -. DR STRING; 4932.YER144C; -. DR MEROPS; C19.006; -. DR GlyGen; P39944; 2 sites, 1 O-linked glycan (2 sites). DR iPTMnet; P39944; -. DR MaxQB; P39944; -. DR PaxDb; 4932-YER144C; -. DR PeptideAtlas; P39944; -. DR EnsemblFungi; YER144C_mRNA; YER144C; YER144C. DR GeneID; 856887; -. DR KEGG; sce:YER144C; -. DR AGR; SGD:S000000946; -. DR SGD; S000000946; UBP5. DR VEuPathDB; FungiDB:YER144C; -. DR eggNOG; KOG1868; Eukaryota. DR GeneTree; ENSGT00940000173629; -. DR HOGENOM; CLU_005922_1_0_1; -. DR InParanoid; P39944; -. DR OMA; PFVHTYE; -. DR OrthoDB; 227085at2759; -. DR BioCyc; YEAST:G3O-30305-MONOMER; -. DR BioGRID-ORCS; 856887; 5 hits in 10 CRISPR screens. DR PRO; PR:P39944; -. DR Proteomes; UP000002311; Chromosome V. DR RNAct; P39944; Protein. DR GO; GO:0005935; C:cellular bud neck; IDA:SGD. DR GO; GO:0000131; C:incipient cellular bud site; IDA:SGD. DR GO; GO:0004843; F:cysteine-type deubiquitinase activity; TAS:SGD. DR GO; GO:0016579; P:protein deubiquitination; TAS:SGD. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR CDD; cd02674; Peptidase_C19R; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 1. DR Gene3D; 3.40.250.10; Rhodanese-like domain; 1. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR001394; Peptidase_C19_UCH. DR InterPro; IPR001763; Rhodanese-like_dom. DR InterPro; IPR036873; Rhodanese-like_dom_sf. DR InterPro; IPR018200; USP_CS. DR InterPro; IPR028889; USP_dom. DR PANTHER; PTHR21646; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE; 1. DR PANTHER; PTHR21646:SF95; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 4-RELATED; 1. DR Pfam; PF00581; Rhodanese; 1. DR Pfam; PF00443; UCH; 1. DR SMART; SM00450; RHOD; 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR SUPFAM; SSF52821; Rhodanese/Cell cycle control phosphatase; 1. DR PROSITE; PS50206; RHODANESE_3; 1. DR PROSITE; PS00972; USP_1; 1. DR PROSITE; PS00973; USP_2; 1. DR PROSITE; PS50235; USP_3; 1. PE 1: Evidence at protein level; KW Hydrolase; Protease; Reference proteome; Thiol protease; KW Ubl conjugation pathway. FT CHAIN 1..805 FT /note="Ubiquitin carboxyl-terminal hydrolase 5" FT /id="PRO_0000080590" FT DOMAIN 159..283 FT /note="Rhodanese" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00173" FT DOMAIN 446..804 FT /note="USP" FT REGION 359..380 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 455 FT /note="Nucleophile" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10092, FT ECO:0000255|PROSITE-ProRule:PRU10093" FT ACT_SITE 761 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10092, FT ECO:0000255|PROSITE-ProRule:PRU10093" SQ SEQUENCE 805 AA; 92261 MW; 884054A66370DFF7 CRC64; MGSEQALSEV VESAKERFGR LRHLVQKFLD DDDVPQECLP LLQECAEIWS SYVDACQDIT MQAPKEDANR LSKGFLRLNE TAFLYYMIVY TLLEDTLPRL KEFSSNKDQN VRNLYGERIQ LLHNDPNIER IRNVIENYPK FIQLQTIEPG KLSSMLHFHG DALLLIDVRP RSEFVRAHIK CKNIICIDPA SFKDSFTDQQ IESVSLITSP HSDITFFSNR DKFKFIILYT DTQLHNNFQQ RQTRILAKIL SQNSVIKPLS GTKILILENG FSNWVKLGGA YQSSVSETAH LTSSSSTPAF GSPQVPTGLF NQKSLSPNKD KSMPMVSMNT QPLLTTVQRP QLPLYYSDLP IIPQPSPNRN SPTVQKFSPH PPTTLSKLNT PSTIQNKANT VERISPDIRA AQAHAYLPPA SNVFSPRIPP LPQQNLSSSR QTILNNSQVL DLDLIVGLEN IGNCCYMNCI LQCLVGTHDL VRMFLDNTYL NFINFDSSRG SKGLLAKNFA ILVNNMHRHG AFTPPNVRTI PVQTIQFKKI CGHINPMYSD SMQQDCQEFC QFLLDGLHED LNQNGSKKHL KQLSDEEERM REKMSIRKAS ALEWERFLLT DFSAIIDLFQ GQYASRLQCQ VCEHTSTTYQ TFSVLSVPVP RVKTCNILDC FREFTKCERL GVDEQWSCPK CLKKQPSTKQ LKITRLPKKL IINLKRFDNQ MNKNNVFVQY PYSLDLTPYW ARDFNHEAIV NEDIPTRGQV PPFRYRLYGV ACHSGSLYGG HYTSYVYKGP KKGWYFFDDS LYRPITFSTE FITPSAYVLF YERIF //